Fairfield, CT - (December 4, 2008) - Competitive Technologies, Inc. (NYSE Alternext US: CTT) announced today that it has been notified by the NYSE Alternext US that CTT is in financial non-compliance with continued listing standards of the exchange. Under the standards, CTT has 30 days to respond with a business plan that demonstrates its ability to achieve, within 18 months, compliance with the listing standards. CTT will submit such a plan. In the meantime, the stock continues to trade at NYSE Alternext US.

CTT was notified on December 2, 2008 that it had fallen below the Section 1003(a)(ii) standard of the NYSE Alternext US Company Guide by having shareholders' equity of less than $4 million and losses from continuing operations and/or net losses in three out of its four most recent fiscal years as reported and fully disclosed in the most recent Form 10-K filed October 28, 2008.

"In the business plan we submit, we will emphasize the progress in the marketing of our pain management medical device, including the four signed country-exclusive distribution agreements for India, Korea, Bangladesh and Malaysia, the CE Mark approval for sale of the device in Europe, and our pending FDA 510(k) application for sale of the device in the United States," said John B. Nano, CTT's Chairman President, and CEO. "We will also describe the equity financing arrangement we signed in July 2008 with Fusion Capital for up to $5.0 million of cash through sale of our common stock, at our option. Of the $5.0 million, $4.9 million remained available at October 31, 2008."